Gabriela Loperena Oropeza, MD
Endocrinology, Diabetes & Metabolism · Tacoma, WANPI 1548452162
Payments from drug & device makers
Across 664 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Medtronic$2K
- Amgen$1K
- Boehringer Ingelheim$997
- Sanofi-aventis U.S. LLC$714
- AstraZeneca$568
- plus $5K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 173 | $1,852 |
| Medtronic(2 entities) | 42 | $1,509 |
| Amgen(2 entities) | 51 | $1,251 |
| Boehringer Ingelheim | 53 | $997 |
| Sanofi-aventis U.S. LLC | 47 | $714 |
| AstraZeneca(2 entities) | 33 | $568 |
| Lilly USA, LLC | 42 | $537 |
| Tandem Diabetes Care, Inc. | 8 | $357 |
| Dexcom, Inc. | 14 | $355 |
| Bayer | 12 | $299 |
| Corcept Therapeutics | 13 | $284 |
| Johnson & Johnson | 27 | $278 |
| Antares Pharma, Inc. | 15 | $274 |
| Xeris Pharmaceuticals, Inc. | 13 | $233 |
| Amryt Pharma Holdings Ltd | 8 | $203 |
| Merck | 22 | $192 |
| Novartis | 9 | $190 |
| AbbVie | 13 | $173 |
| Insulet Corporation | 8 | $154 |
| Mannkind Corporation | 12 | $152 |
| Abbott | 6 | $127 |
| Recordati_rare_diseases_inc. | 4 | $120 |
| Radius Health, Inc. | 7 | $116 |
| IBSA Pharma Inc. | 6 | $115 |
| Amarin Pharma, Inc. | 6 | $109 |
| Regeneron Healthcare Solutions, Inc. | 3 | $75 |
| Lifescan, Inc. | 4 | $74 |
| Ascensia Diabetes Care US Inc. | 2 | $42 |
| BETA Bionics, Inc. | 2 | $35 |
| Kyowa Kirin, Inc. | 1 | $30 |
| Pfizer | 2 | $27 |
| Companion Medical, Inc. | 1 | $27 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Nevro Corp. | 1 | $16 |
| Aegerion Pharmaceuticals, Inc. | 1 | $15 |
| Cequr Corporation | 1 | $10 |
How this compares
$11,545 in reported general payments places this provider in the 70th percentile of 161 endocrinology, diabetes & metabolism providers in Washington.
See all endocrinology, diabetes & metabolism providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Tacoma
- Ronald GrafTacoma$478K
- Ayesha JameelTacoma$9K
- Rebecca OverTacoma$6K
- Rani KulkarniTacoma$3K
- Ronald BrazgRenton$17.9M
- Frances BroylesSeattle$5.6M
- Leslie KlaffRenton$2.8M
- Carla GreenbaumSeattle$2.6M
- Irl HirschSeattle$2.4M
- William HagopianSeattle$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.